Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jun 3 2025

Full Issue

Brain-Implantable Device Companies Vie For FDA Approval

Paradromics' Brain-Computer Interface has been tested briefly in a patient with epilepsy. Neuralink, Precision Neuroscience, and Synchron also have devices in the works. Other news looks at a combination drug to treat extensive-stage small cell lung cancer; the MIND diet to protect against Alzheimer's; and more.

Modern Healthcare: Paradromics, Neuralink Race For FDA Approval In BCI Market

The race to secure approval for brain-implantable devices that allow computers to be controlled by thought is picking up speed, showing promise for patients and the companies behind them. The devices, which are implanted in or on the surface of the brain, use brain signals to enable patients with paralysis, speech impairments and severe neurological disorders to speak and control computers and smartphones, among other things. It could be a game changer for patients with conditions like amyotrophic lateral sclerosis, more commonly known as Lou Gehrig's disease, as well as brainstem strokes and spinal cord injuries. (Dubinsky, 6/2)

The Wall Street Journal: Roche’s Tecentriq With Lurbinectedin Increases Survival From Small-Cell Lung Cancer, Study Says

Roche said Tecentriq combined with lurbinectedin shows significant survival benefits for patients with extensive-stage small cell lung cancer. The Swiss pharmaceutical company said Tuesday that late-stage trials showed the combination led to a 46% reduction in the risk of the disease progressing or death, and 27% reduction in the risk of death. (Whittaker, 6/2)

CBS News: This Diet Can Protect Your Brain From Alzheimer's Even If Started Later In Life, New Study Suggests

People who follow a MIND diet, even if started later in life, were significantly less likely to develop Alzheimer's disease or related forms of dementia, according to new research. The MIND diet stands for "Mediterranean-DASH Intervention for Neurodegenerative Delay" and combines many elements of the Mediterranean diet and DASH ("Dietary Approaches to Stop Hypertension"). It emphasizes brain-healthy foods like leafy greens, berries, nuts and olive oil. (Moniuszko, 6/2)

Fortune Well: Could Eating Fiber Reduce The PFAS Chemicals In Your Blood?

Research estimates that 200 million people in the U.S. rely on tap water contaminated with PFAS, or forever chemicals. This class of chemicals includes more than 9,000 potentially hazardous synthetic compounds linked to cancer and endocrine disruption—and they have become ubiquitous, lurking in everything from non-stick pans to plastic food containers and even beer. PFAS have earned the nickname forever chemicals because of their resistance to breaking down—both in the environment and the human body. (Freedman, 6/2)

CIDRAP: Study Finds Live Avian Flu Virus In Raw Milk For More Than 1 Day At Room Temperature, 1 Week In Fridge

Researchers conducting a lab study published on the preprint server medRxiv detected infectious flu viruses in raw cow and sheep milk for over a day at room temperature and more than a week when refrigerated. The results of the non–peer-reviewed research highlight the risk of contracting H5N1 avian flu from consuming unpasteurized dairy products and from occupational exposure in dairies, the UK investigators said. (Van Beusekom, 6/2)

CIDRAP: Flu, RSV Linked To Higher Odds Of Secondary Bacterial Infection

A retrospective analysis of patients at Veterans Affairs (VA) hospitals found that influenza and respiratory syncytial virus (RSV) is associated with increased risk of secondary Streptococcus pneumoniae infection but COVID-19 isn't, researchers reported late week in Clinical Infectious Diseases. (Dall, 6/2)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF